Remove 2021 Remove Bipolar disorder Remove Genetics and mental health
article thumbnail

FDA Requires New Label Warning of Weight Loss Risk in Pediatric Patients Taking Extended-Release Stimulants for ADHD

Psychiatric Times

SHOW MORE The FDA will update ADHD medication labels, warning of weight loss risks in children under 6, urging careful monitoring by health care professionals. Healthcare professionals should monitor weight and growth in young patients on these medications and consider alternative treatments if adverse effects occur.

article thumbnail

NRx Pharmaceuticals Applies for FDA National Priority Voucher for Intravenous Ketamine (NRX-100)

Psychiatric Times

1 The newly announced CNPV pathway was introduced by FDA Commissioner Marty Makary, MD, MPH, on June 17, 2025, and is intended to expedite reviews for medications that address US public health priorities. The CNPV program, introduced by FDA Commissioner Marty Makary, aims to reduce review times to 1-2 months for eligible applications.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Prodromal Symptoms of Schizophrenia: Understanding and Addressing Challenges

Psychiatric Times

Studies in Australia and the United States followed individuals with subthreshold psychotic symptoms and functional decline, along with a genetic risk for schizophrenia, over time. Research indicates that only 20% to 40% of individuals who meet ultra–high risk (UHR) criteria convert to psychosis within 2 to 4 years.

article thumbnail

Criticisms That Establishment Psychiatry Can and Cannot Tolerate

Mad in America

Establishment psychiatry does acknowledge that emotional suffering and behavioral disturbanceswhat it calls mental illnesseshave biological-psychological-social roots. medical schools. Worldwide, there are parallels to U.S.

article thumbnail

Why Failed Psychiatry Lives On: Its Industrial Complex, Politics, & Technology Worship

Mad in America

Thomas Insel, director of the National Institute of Mental Health (NIMH) from 2002-2015, acknowledged in 2011, “Whatever we’ve been doing for five de­cades, it ain’t working. adults now takes an antidepressant”; however, Time continued, “Mental health is getting worse by multiple metrics. As of late 2022, just 31% of U.S.

article thumbnail

Critical Psychiatry Textbook, Chapter 16: Is There Any Future for Psychiatry? (Part Five)

Mad in America

667 In an NIMH study of 547 patients that compared six-year outcomes for depressed people treated for the disorder and those who eschewed medical treatment, the treated patients were three times more likely than untreated ones to suffer a cessation of their principal social role and nearly seven times more likely to become incapacitated.

article thumbnail

How to Explain Top Psychiatrists’ “Dr. Strangelove Exuberance” Unchecked by Reality

Mad in America

E xuberant individuals who disregard societal consensus reality are routinely diagnosed by psychiatrists with bipolar disorder; however, among psychiatrists themselves, exuberance about psychiatry regardless of the reality of psychiatry’s repeated scientific failures makes one a leading psychiatrist. Thomas Insel, quoted in 2017. “To